Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.
复制标题

DOI:
10.1073/pnas.0902749106
复制
发表时间:
2009-05-05
影响因子:
11.1
通讯作者:
Major M
Major M
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Zhang P;Zhong L;Struble EB;Watanabe H;Kachko A;Mihalik K;Virata ML;Alter HJ;Feinstone S;Major M

文献摘要

参考文献

被引文献

相似文献

Using human immune globulins made from antihepatitis C virus (HCV)-positive plasma, we recently identified two antibody epitopes in the E2 protein at residues 412–426 (epitope I) and 434–446 (epitope II). Whereas epitope I is highly conserved among genotypes, epitope II varies. We discovered that epitope I was implicated in HCV neutralization whereas the binding of non-neutralizing antibody to epitope II disrupted virus neutralization mediated by antibody binding at epitope I. These findings suggested that, if this interfering mechanism operates in vivo during HCV infection, a neutralizing antibody against epitope I can be restrained by an interfering antibody, which may account for the persistence of HCV even in the presence of an abundance of neutralizing antibodies. We tested this hypothesis by affinity depletion and peptide-blocking of epitope-II-specific antibodies in plasma of a chronically HCV-infected patient and recombinant E1E2 vaccinated chimpanzees. We demonstrate that, by removing the restraints imposed by the interfering antibodies to epitope-II, neutralizing activity can be revealed in plasma that previously failed to neutralize viral stock in cell culture. Further, cross-genotype neutralization could be generated from monospecific plasma. Our studies contribute to understanding the mechanisms of antibody-mediated neutralization and interference and provide a practical approach to the development of more potent and broadly reactive hepatitis C immune globulins.
DOI: 10.1038/nm1698
发表时间: 2008-01-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Law, Mansun;Maruyama, Toshiaki;Burton, Dennis R.
通讯作者: Burton, Dennis R.
DOI: 10.1128/jvi.01986-07
发表时间: 2008-01-01
影响因子: 5.4
作者:
Perotti, Mario;Mancini, Nicasio;Burioni, Roberto
通讯作者: Burioni, Roberto
DOI: 10.1126/science.1114016
发表时间: 2005-07-22
期刊: SCIENCE
影响因子: 56.9
作者:
Lindenbach, BD;Evans, MJ;Rice, CM
通讯作者: Rice, CM
DOI: 10.1128/jvi.73.8.6235-6244.1999
发表时间: 1999-08-01
影响因子: 5.4
作者:
Flint, M;Maidens, C;McKeating, JA
通讯作者: McKeating, JA
DOI: 10.1016/j.vaccine.2003.09.010
发表时间: 2004-02-25
期刊: VACCINE
影响因子: 5.5
作者:
Puig, M;Major, ME;Feinstone, SM
通讯作者: Feinstone, SM